Your browser doesn't support javascript.
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add filters

Database
Language
Document Type
Year range
1.
Nat Commun ; 12(1): 4629, 2021 07 30.
Article in English | MEDLINE | ID: covidwho-1333939

ABSTRACT

Since the outbreak of the SARS-CoV-2 pandemic, there have been intense structural studies on purified viral components and inactivated viruses. However, structural and ultrastructural evidence on how the SARS-CoV-2 infection progresses in the native cellular context is scarce, and there is a lack of comprehensive knowledge on the SARS-CoV-2 replicative cycle. To correlate cytopathic events induced by SARS-CoV-2 with virus replication processes in frozen-hydrated cells, we established a unique multi-modal, multi-scale cryo-correlative platform to image SARS-CoV-2 infection in Vero cells. This platform combines serial cryoFIB/SEM volume imaging and soft X-ray cryo-tomography with cell lamellae-based cryo-electron tomography (cryoET) and subtomogram averaging. Here we report critical SARS-CoV-2 structural events - e.g. viral RNA transport portals, virus assembly intermediates, virus egress pathway, and native virus spike structures, in the context of whole-cell volumes revealing drastic cytppathic changes. This integrated approach allows a holistic view of SARS-CoV-2 infection, from the whole cell to individual molecules.


Subject(s)
COVID-19/immunology , SARS-CoV-2/immunology , Virus Assembly/immunology , Virus Release/immunology , Virus Replication/immunology , Animals , COVID-19/epidemiology , COVID-19/virology , Chlorocebus aethiops , Cryoelectron Microscopy , Electron Microscope Tomography , Humans , Pandemics/prevention & control , SARS-CoV-2/physiology , SARS-CoV-2/ultrastructure , Vero Cells , Virus Assembly/physiology , Virus Release/physiology , Virus Replication/physiology
2.
ACS Cent Sci ; 7(4): 594-602, 2021 Apr 28.
Article in English | MEDLINE | ID: covidwho-1225486

ABSTRACT

Vaccine development against the SARS-CoV-2 virus focuses on the principal target of the neutralizing immune response, the spike (S) glycoprotein. Adenovirus-vectored vaccines offer an effective platform for the delivery of viral antigen, but it is important for the generation of neutralizing antibodies that they produce appropriately processed and assembled viral antigen that mimics that observed on the SARS-CoV-2 virus. Here, we describe the structure, conformation, and glycosylation of the S protein derived from the adenovirus-vectored ChAdOx1 nCoV-19/AZD1222 vaccine. We demonstrate native-like post-translational processing and assembly, and reveal the expression of S proteins on the surface of cells adopting the trimeric prefusion conformation. The data presented here confirm the use of ChAdOx1 adenovirus vectors as a leading platform technology for SARS-CoV-2 vaccines.

SELECTION OF CITATIONS
SEARCH DETAIL